Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Today, Ajinomoto Co., Inc. ("Ajinomoto Co.") (TSE: 2802) launched a new version of its StemFit™ iPSC expansion medium. The enhanced version...
Today, Ajinomoto Co., Inc. ("Ajinomoto Co.") (TSE: 2802) launched a new version of its StemFit™ iPSC expansion medium. The enhanced version...
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication of a new study...
A novel canine cancer study funded by Morris Animal Foundation and the Golden Retriever Foundation® is leveraging artificial intelligence to pioneer an innovative...
LifeLabs, a leading provider of laboratory diagnostic services, is thrilled to introduce our latest offering: At-Home Self-Collection Kits. LifeLabs’...
The One Health Trust, funded by the World Health Organization and the British Academy, hosted a two-day workshop focused on...
Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced the publication of new data analysis from a long-term Early Access Program (“EAP”)...
Revive Drip, a leading mobile intravenous therapy (IV) company providing customized hydration and immune-boosting therapy throughout the Puget Sound, announced...
Just in time for the start of the outdoor season, Jackery is offering deep discounts on selected power stations and solar...
Following last year's successful launch of XATEPA® in Germany, the cannabinoid-based product will now become available to patients in the United Kingdom during Q2...